<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04755166</url>
  </required_header>
  <id_info>
    <org_study_id>LRA humans</org_study_id>
    <nct_id>NCT04755166</nct_id>
  </id_info>
  <brief_title>Horizontal Augmentation With Deproteinized Bovine Bone Mineral Alone or in Combination With Particulate Autogenous Bone</brief_title>
  <official_title>Lateral Ridge Augmentation With Two Different Compositions of Deproteinized Bovine Bone and Autogenous Bone: A Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NU-Hospital Organization, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aalborg University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NU-Hospital Organization, Sweden</source>
  <brief_summary>
    <textblock>
      Background: Placement of oral implants is frequently compromised due to atrophy of the&#xD;
      alveolar process. Lateral ridge augmentation with an autogenous bone block is frequently&#xD;
      necessary to increase the width of the alveolar process before implant installation. However,&#xD;
      harvesting of an autogenous bone block is associated with donor site morbidity. Consequently,&#xD;
      bone substitutes alone or in combination with particulate autogenous bone graft are used&#xD;
      increasingly to simplify the surgical procedure. Animal and human studies evaluating lateral&#xD;
      ridge augmentation with Bio-Oss alone or in combination with particulate autogenous bone&#xD;
      graft have demonstrated new bone formation and high implant survival. However, the optimal&#xD;
      ratio of Bio-Oss and particulate autogenous bone graft for lateral ridge augmentation and&#xD;
      long-term implant survival is unknown.&#xD;
&#xD;
      Purpose: Test the H0-hypothesis of no difference in long-term implant survival, newly formed&#xD;
      bone, volumetric stability of the graft, gained width of the alveolar process and patient&#xD;
      satisfaction after lateral ridge augmentation with Bio-Oss alone or in combination with a&#xD;
      diminutive amount of autogenous bone graft.&#xD;
&#xD;
      Material and methods: lateral ridge augmentation will be performed in 20 adults with two&#xD;
      different ratios of Bio-Oss and autogenous bone graft after a split mouth design. Clinical&#xD;
      and radiological measurements will evaluate the long-term implant survival. Cone beam&#xD;
      computer tomography (CBCT) will be obtained preoperatively, immediately postoperatively,&#xD;
      prior to implant placement, 2 years after implant installation and 5 years after implant&#xD;
      installation to estimate the volumetric changes of the augmented area. Moreover, the amount&#xD;
      of newly formed bone will be estimated by histologic evaluation after implant placement.&#xD;
&#xD;
      Conclusion: Long-term implant survival has never been evaluated after lateral ridge&#xD;
      augmentation with Bio-Oss alone or in combination with a diminutive amount of autogenous bone&#xD;
      graft.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Newly formed bone</measure>
    <time_frame>10 months after treatment</time_frame>
    <description>Amount of newly formed bone in the graft assessed by histological measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Height in mm</measure>
    <time_frame>10 months after treatment</time_frame>
    <description>Height of the augmented area assessed by radiological measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume in mm3</measure>
    <time_frame>10 months after treatment</time_frame>
    <description>Volume of the augmented area assessed by clinical and radiological measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant survival</measure>
    <time_frame>1 year after placement of the implants</time_frame>
    <description>Survival of implants placed in the graft assessed by clinical and radiological measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant survival</measure>
    <time_frame>3 year after placement of the implants</time_frame>
    <description>Survival of implants placed in the graft assessed by clinical and radiological measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant survival</measure>
    <time_frame>5 year after placement of the implants</time_frame>
    <description>Survival of implants placed in the graft assessed by clinical and radiological measurements</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Edentulous Jaw</condition>
  <arm_group>
    <arm_group_label>100:0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 % bone substitute, 0% autogenous bone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>90:10</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>90% bone substitute, 10% autogenous bone</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lateral ridge augmentation</intervention_name>
    <arm_group_label>100:0</arm_group_label>
    <arm_group_label>90:10</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Total or partial bilateral edentulism&#xD;
&#xD;
          -  Horizontal bone width less than 4 mm at planned sites of implant installation or need&#xD;
             of augmentation of aesthetic reasons for optimal implant placement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncontrolled systematic disease&#xD;
&#xD;
          -  History of radiation in the area&#xD;
&#xD;
          -  Smoking habits (free of smoking habits more than 1 month prior to treatment)&#xD;
&#xD;
          -  Treatment with bisphosphonates&#xD;
&#xD;
          -  Patients who cannot complete the 5-year observation period&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanna Aludden, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NU Hospital Organisation, Trollhättan, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NU Hospital Organization</name>
      <address>
        <city>Trollhättan</city>
        <zip>46273</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 7, 2021</study_first_submitted>
  <study_first_submitted_qc>February 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>February 11, 2021</last_update_submitted>
  <last_update_submitted_qc>February 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NU-Hospital Organization, Sweden</investigator_affiliation>
    <investigator_full_name>Hanna Aludden</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Bone substitutes</keyword>
  <keyword>Imaging-Three-Dimensional</keyword>
  <keyword>alveolar ridge augmentation</keyword>
  <keyword>dental implants</keyword>
  <keyword>Bio-Oss</keyword>
  <keyword>Guided bone regeneration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Jaw, Edentulous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

